1.61
Synlogic Inc stock is traded at $1.61, with a volume of 11,042.
It is up +0.63% in the last 24 hours and down -9.55% over the past month.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
See More
Previous Close:
$1.60
Open:
$1.6
24h Volume:
11,042
Relative Volume:
0.38
Market Cap:
$18.84M
Revenue:
$3.37M
Net Income/Loss:
$-57.28M
P/E Ratio:
-0.1497
EPS:
-10.7522
Net Cash Flow:
$-51.83M
1W Performance:
-4.17%
1M Performance:
-9.55%
6M Performance:
+41.23%
1Y Performance:
+14.59%
Synlogic Inc Stock (SYBX) Company Profile
Name
Synlogic Inc
Sector
Industry
Phone
617-659-2802
Address
PO BOX 30, WINCHESTER, MA
Compare SYBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYBX
Synlogic Inc
|
1.61 | 18.72M | 3.37M | -57.28M | -51.83M | -10.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Synlogic Inc Stock (SYBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-21-19 | Downgrade | Oppenheimer | Outperform → Perform |
| Apr-30-19 | Initiated | Jefferies | Buy |
| Dec-13-18 | Initiated | Chardan Capital Markets | Buy |
| Mar-19-18 | Initiated | H.C. Wainwright | Buy |
| Jan-29-18 | Initiated | Piper Jaffray | Overweight |
View All
Synlogic Inc Stock (SYBX) Latest News
How Synlogic Inc. stock performs in weak economyJuly 2025 Technicals & Real-Time Volume Triggers - newser.com
Is Synlogic Inc. stock a smart buy before Fed meetingEntry Point & Risk Managed Investment Signals - newser.com
Can Synlogic Inc. stock maintain growth trajectory2025 Sector Review & Weekly High Conviction Ideas - newser.com
Will Synlogic Inc. stock sustain high P E ratiosJuly 2025 News Drivers & Accurate Entry and Exit Point Alerts - newser.com
What Wall Street predicts for Synlogic Inc. stock priceShort Setup & Capital Efficiency Focused Strategies - newser.com
Is Synlogic Inc. stock supported by strong cash flowsEarnings Overview Summary & Free High Return Stock Watch Alerts - newser.com
Can Synlogic Inc. stock sustain revenue growthRisk Management & Weekly Top Performers Watchlists - newser.com
How institutional buying supports Synlogic Inc. stockSwing Trade & Daily Stock Trend Reports - newser.com
Synlogic Inc. stock outlook for YEARMarket Performance Report & Precise Buy Zone Tips - newser.com
How Synlogic Inc. stock reacts to oil prices2025 Price Momentum & Weekly High Return Stock Forecasts - newser.com
Will breakout in Synlogic Inc. lead to full recovery2025 Bull vs Bear & Weekly Breakout Watchlists - newser.com
Will Synlogic Inc. stock outperform international peersEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Can Synlogic Inc. stock deliver sustainable ROEJuly 2025 WrapUp & Reliable Entry Point Trade Alerts - newser.com
Tools to monitor Synlogic Inc. recovery probabilityGap Up & Community Verified Trade Signals - newser.com
Capital Small Finance Bank Limited Company Forecast Revenue EPS and Valuation OutlookSector Performance Review & Free Realize Exceptional Returns - earlytimes.in
Synlogic, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Synlogic Inc Stock Analysis and ForecastDividend Reinvestment Plans & Explosive Growth Opportunities - earlytimes.in
[DEF 14A] SYNLOGIC, INC. Definitive Proxy Statement - Stock Titan
Synlogic Inc Stock (SYBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):